1. Home
  2. VIVS vs GNLN Comparison

VIVS vs GNLN Comparison

Compare VIVS & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$0.16

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$1.72

Market Cap

2.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIVS
GNLN
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Durable Goods
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.1M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
VIVS
GNLN
Price
$0.16
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 721.4K
20.3K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 21.57
EPS
★ N/A
N/A
Revenue
$4,603,000.00
★ $13,275,000.00
Revenue This Year
$228,144.28
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.82
N/A
52 Week Low
$0.14
$1.51
52 Week High
$3.40
$139.60

Technical Indicators

Market Signals
Indicator
VIVS
GNLN
Relative Strength Index (RSI) 37.34 32.39
Support Level N/A $1.51
Resistance Level $0.30 $2.14
Average True Range (ATR) 0.02 0.20
MACD 0.00 -0.06
Stochastic Oscillator 36.23 0.00

Price Performance

Historical Comparison
VIVS
GNLN

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.

Share on Social Networks: